Contact
William H. Frishman, M.D., is an internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology, and geriatrics. Dr. Frishman has authored and co-authored more than 900 original articles, reviews, and book chapters. He has also edited, co-edited, authored, and co-authored twelve full-length textbooks, including the major text Cardiovascular Pharmacotherapeutics (McGraw-Hill), now in its second edition. Dr. Frishman published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007), and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.
Education
- M.D., Boston University School of Medicine
Areas of Expertise
- Cardiovascular Pharmacology
- Clinical Epidemiology
- Geriatrics
Honors and Awards
- Teaching Scholar Award of the American Heart Association
- Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
- Distinguished Teacher Award, Alpha Omega Alpha National Medical Honor Society
Research
Dr. Frishman has served as a principal investigator in multiple NIH-funded studies, including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Women's Health Initiative Trial" (WHI), and the "Bronx Longitudinal Aging Study."
Publications
- Basta D, Al Refaei A, Msinjili L, et. al. "Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease: Shared Mechanisms and Therapeutic Opportunities." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001298
- Swamynathan R, Dolan L, Frishman WH, et. al. "Chronic Kidney Disease and Its Role in Cardiovascular Disease." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001309
- Jha M, Matawala K, Jairaman S, et. al. "Trends and Disparities in Chronic Rheumatic Heart Disease Mortality in the United States (1999-2024) and Projections to 2050." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001316
- Kaiser M, Lewis TA, Malekan M, et. al. "Understanding Dysfunctional Autophagy and Mitophagy in Inflammatory Cardiovascular Disease." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001302
- Pillai AA, Godin SL, Frishman WH, et. al. "Triple Hormone Receptor Agonism: The Role of Retatrutide in Addressing Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Comprehensive Review." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001310
- Abdullah M, Khalid N, Frishman WH, et. al. "Finerenone and Empagliflozin in Type 2 Diabetes." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001308
- Mohammadi A, Khatami S, Ebrahimi S, et. al. "From Lumen to Myocardium With Artificial Intelligence: A Clinician's Guide to Comprehensive Cardiac CT." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001293
